CV Lattes
ResearcherID
ORCID
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduate at Medicina from Faculdade de Ciências Médicas de Santos (1978) and ph.d. at Nefrology from Universidade de São Paulo (1989). Has experience in Medicine, focusing on Nefrology, acting on the following subjects: transplante renal, renal transplantation, transplante, insuficiência renal crônica and kidney transplantation. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Sensitized patients to HLA (Class I or II PRA e 10%) represents 20-25% of renal transplanted patient. They are usually over immunosuppressed to prevent rejection and therefore develop more infections like CMV disease. There is no current immunosuppressive regimen that addresses the demands for these patients. We hypothesize that adding everolimus, an mTOR inhibitor with different site of …
For the treatment of osteoporosis in the general population, a number of drugs reduce BMD (bone mineral density) loss and the rate of incident fractures. For instance, bisphosphonates improve BMD, reduce hip fracture rates and decrease mortality in post-menopausal women. Because of lack of data on safety and an increased risk of adverse effects, the use of these drugs is controversial in …
CMV disease is a challenge to the success of renal transplantation. Recently, we analyzed data from 792 renal transplant recipients performed at our hospital between 1999 and 2005. After the usual exclusions, 663 patients were analyzed. This population showed that the incidence of CMV disease is stable and occurs in approximately 20-22% of all patients and invasive disease in approximatel…
(Only some records are available in English at this moment)
Kidney transplant (KTx) recipients with HLA sensitization have high risk of graft rejection. In order to improve the results of these KTx, a prospective and randomized study aimed to analyze a possible benefit of the addition of everolimus (EVR) to the immunosuppression based on tacrolimus (TAC), mycophenolate mofetil (MMF) and prednisone (PRED) is currently ongoing in the institution. Ho…
| 1 / 1 | Ongoing grants |
| 8 / 5 | Completed research grants |
| 2 / 2 | Completed scholarships in Brazil |
| 11 / 8 | All research grants and scholarships |
| Associated processes | |